← Back to Search

Educational Interventions for High Blood Pressure (MPC Trial)

N/A
Recruiting
Led By John Billimek, PhD
Research Sponsored by University of California, Irvine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up collected for analysis at baseline, upon completion of intervention period and upon completion of outcome assessment period at 1-month and 6-month follow up.
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare two ways of teaching people with uncontrolled hypertension how to better manage their blood pressure medication.

Who is the study for?
This trial is for adults over 18 with uncontrolled high blood pressure (above 140/90 mmHg), who have visited the study clinic in the last year, and identify as Hispanic. They must speak Spanish or English. People with advanced chronic kidney disease (stage 4 or 5) cannot participate.
What is being tested?
The trial is testing two educational programs: 'Mi Propio Camino' and 'Habilidades para Controlar la Presion'. These are designed to help participants better adhere to their blood pressure medication regimen.
What are the potential side effects?
Since this trial focuses on educational interventions rather than medications, there are no direct side effects from drugs being tested. However, changes in how participants manage their medications could indirectly affect their health.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~collected for analysis at baseline, upon completion of intervention period and upon completion of outcome assessment period at 1-month and 6-month follow up.
This trial's timeline: 3 weeks for screening, Varies for treatment, and collected for analysis at baseline, upon completion of intervention period and upon completion of outcome assessment period at 1-month and 6-month follow up. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Medication Adherence (Objective)
Secondary study objectives
Activation of behavioral strategies
Blood Pressure
Medication Adherence (Subjective)
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mi Propio Camino (MPC; My Own Way)Experimental Treatment1 Intervention
Participants will complete the MPC intervention alongside usual care for hypertension
Group II: Habilidades para Controlar la Presion (HCP; Skills for Blood Pressure Control)Active Control1 Intervention
Participants will complete the HCP intervention alongside usual care for hypertension.

Find a Location

Who is running the clinical trial?

University of California, IrvineLead Sponsor
560 Previous Clinical Trials
1,929,602 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,922 Previous Clinical Trials
47,760,246 Total Patients Enrolled
John Billimek, PhDPrincipal InvestigatorUniversity of California, Irvine
1 Previous Clinical Trials
190 Total Patients Enrolled

Media Library

Mi Propio Camino (MPC) Clinical Trial Eligibility Overview. Trial Name: NCT04585594 — N/A
High Blood Pressure Research Study Groups: Mi Propio Camino (MPC; My Own Way), Habilidades para Controlar la Presion (HCP; Skills for Blood Pressure Control)
High Blood Pressure Clinical Trial 2023: Mi Propio Camino (MPC) Highlights & Side Effects. Trial Name: NCT04585594 — N/A
Mi Propio Camino (MPC) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04585594 — N/A
~98 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top